CClinicalTrials.gg
CompletedNCT03664310Updated Feb 1, 2021

Transdiagnostic Sleep and Anxiety Treatment

An interventional study of FSET Anxiety and Sleep Treatment and Control in Anxiety Disorders, sponsored by Florida State University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-01.

Sponsored by Florida State University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Aug 2017, registered Sep 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
61
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Background: Anxiety and insomnia disorders are two of the most common and costly mental health conditions. These disorders are frequently comorbid, but current treatment approaches do not target both. To streamline treatment for these commonly comorbid conditions, a novel, computerized intervention was developed targeting a transdiagnostic factor, safety aids, which are cognitive or behavioral strategies individuals use to cope with distress associated with anxiety or insomnia, that paradoxically exacerbate symptoms. A randomized controlled trial was conducted to determine the acceptability and efficacy of this newly developed intervention. Method: Young adults (N = 61) with elevated anxiety and insomnia symptoms were randomized to receive the anxiety-insomnia intervention or a computerized control condition focused on general physical health behaviors. After the intervention, participants were followed up at one week and one month and completed self-report measures.

02

Conditions studied

  • Anxiety Disorders

Browse trials for

03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 61 is below the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Florida State University is the lead sponsor of 241 studies on the registry; 46 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 9 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • 1 SD above the mean in anxiety and insomnia symptoms
  • Interest in improving anxiety and sleep

Exclusion criteria

Exclusion Criteria:

  • Participating in another clinical trial
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
61 participants (actual)

Study arms

  • Experimental
    FSET Anxiety and Sleep Treatment

    The FSET Anxiety and Sleep Treatment (FAST) is a brief, 45-minute computerized intervention that can be accessed by any device connected to the Internet. The majority of the information is delivered via text. The program contains some interactive features such as quizzes, which direct participants to content, personalized to the individual user (for example screenshots, see Figure 2). FAST contains four modules: motivation, psychoeducation, behavioral tools, and behavior change.

    Other: FSET Anxiety and Sleep Treatment

  • Active comparator
    Control

    The control condition is the Physical Health Education Treatment (PHET) used in several of our laboratory's prior studies (Schmidt, Capron, Raines, \& Allan, 2014). PHET is also a 45-minute computerized intervention, including audio and visual features as well as comprehension quizzes.

    Other: Control

Interventions

  • OtherFSET Anxiety and Sleep Treatment

    Computerized anxiety and insomnia intervention.

  • OtherControl

    Physical health control

06

What researchers measure

Primary outcomes

  1. Safety Aid Scale

    safety aids. Total score (79-445). Higher score indicates worsened symptoms.

    Time frame: Month 1

Secondary outcomes

  1. Sleep Related Behavior Questionnaire

    sleep safety aids. Total score (32-128). Higher scores indicate worse symptoms.

    Time frame: Month 1

  2. Penn State Worry Questionnaire

    worry. Total score (16-80). Higher scores indicate worse symptoms.

    Time frame: Month 1

  3. Dimensional Obsessive Compulsive Scale

    OC symptoms. Total score (0-80). Higher scores indicate worse symptoms.

    Time frame: Month 1

  4. Insomnia Severity Index

    insomnia. Total score (0-28). Higher scores indicate worse symptoms.

    Time frame: Month 1

07

Study locations

1 site
  • Anxiety and Behavioral Health Clinic
    Tallahassee, Florida 32306, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 1, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03664310
Lead sponsor
Florida State University
Responsible party
Norman Schmidt (Professor, Florida State University) — Principal investigator
First posted
Sep 10, 2018
Start date
Aug 1, 2017
Primary completion
May 12, 2018
Completion
May 12, 2018
Last update
Feb 1, 2021

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion